Holen Sie sich die Stockscreener-App
173.45
8.51%
13.60
Vorhandelsmarkt:
170.09
-3.36
-1.94%
Schlusskurs vom Vortag:
$159.85
Offen:
$160.44
24-Stunden-Volumen:
3.49M
Relative Volume:
1.47
Marktkapitalisierung:
$11.50B
Einnahmen:
$409.48M
Nettoeinkommen (Verlust:
$-81.28M
KGV:
-130.55
EPS:
-1.3286
Netto-Cashflow:
$-95.14M
1W Leistung:
+28.04%
1M Leistung:
-6.81%
6M Leistung:
+205.91%
1J Leistung:
+438.50%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$131.23
$178.53
52-Wochen-Spanne:
$23.30
$219.71
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
173.45 | 11.50B | 409.48M | -81.28M | -95.14M | -1.3286 |
VRTX
Vertex Pharmaceuticals Inc
|
529.69 | 134.26B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
214.16 | 85.50B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
813.27 | 83.73B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
891.76 | 56.08B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
373.36 | 42.24B | 5.76B | 514.49M | 1.10B | 4.4813 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-08 | Eingeleitet | Jefferies | Hold |
| 2026-09-09 | Eingeleitet | BWS Financial | Sell |
| 2026-09-09 | Eingeleitet | UBS | Neutral |
| 2026-07-06 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-06-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2026-05-05 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-11-04 | Eingeleitet | Stephens | Overweight |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Zacks Investment Research
Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy? - The Motley Fool
TD Cowen lifts target to USD 190 for Twist Bioscience stock - ad-hoc-news.de
Tax withholding required CFO Adam Laponis to sell 2,462 Twist Bioscience (TWST) shares. - Stock Titan
Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera - GlobeNewswire Inc.
Form 4 Twist Bioscience Corp For: 10 October By Investing.com - Investing.com Canada
Form 4 Twist Bioscience Corp For: 10 October By Investing.com - Investing.com Nigeria
A proposed 2,462-share sale at Twist Bioscience (TWST) includes shares to cover an equity-award tax bill. - Stock Titan
Under a trading plan, Twist Bioscience (TWST) CEO sells 4,548 shares on October 5, 2026. - Stock Titan
After a $56.3M sale, Twist Bioscience (TWST) officer Leproust proposes another share sale. - Stock Titan
Twist Bioscience Insiders Sold Shares Worth Over $9.1M - TradingView
After selling 8,057 shares for taxes, Twist Bioscience (TWST) CFO holds 100,576 shares. - Stock Titan
To cover stock-vesting taxes, HR SVP Paula Green sold 10,088 shares of Twist Bioscience (TWST). - Stock Titan
Tax withholding required Twist Bioscience (TWST) COO to sell 25,714 shares - Stock Titan
Twist Bioscience (TWST) officer sells 1,482 shares in a mandatory sale to cover taxes. - Stock Titan
Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity - GlobeNewswire Inc.
Twist Bioscience (NasdaqGS:TWST) Stock Forecast & Analyst Predictions - Simply Wall Street
Certain Stock Options of Twist Bioscience Corporation are subject to a Lock-Up Agreement Ending on 4-OCT-2026. - marketscreener.com
An officer proposes selling 1,482 Twist Bioscience (TWST) shares, including shares to cover taxes. - Stock Titan
An officer's proposed sale at Twist Bioscience (TWST) includes shares to cover an equity-award tax bill. - Stock Titan
An officer’s proposed share sale at Twist Bioscience (TWST) includes stock to cover a tax obligation. - Stock Titan
An officer plans to sell vested shares at Twist Bioscience (TWST), partly to cover a tax obligation. - Stock Titan
An officer proposes selling vested shares at Twist Bioscience (TWST), partly to cover an equity-award tax obligation. - Stock Titan
Officer Paula Green's proposed Twist Bioscience (NASDAQ: TWST) share sale includes tax coverage. - Stock Titan
After a $56.3M sale, a Twist Bioscience (NASDAQ: TWST) officer proposes selling more shares. - Stock Titan
Form 4 Twist Bioscience Corp For: 27 September By Investing.com - Investing.com Nigeria
Twist Bioscience SVP Paula Green sells $48,654 in common stock - Investing.com
Twist Bioscience SVP Dennis Cho sells $57,590 in company stock - Investing.com
Under a June trading plan, Twist Bioscience (TWST) CEO Emily M. Leproust sold 5,203 shares in 10 transactions. - Stock Titan
A proposed share sale valued at $922,906 names Emily M. Leproust as the Twist Bioscience (TWST) account holder. - Stock Titan
Twist Bioscience Corp Stock (TWST) Moved Up by 11.04% on Sep 24: A Full Analysis - TradingKey
At $165.4910 a share, Twist Bioscience (TWST) CEO Emily M. Leproust sold stock to cover taxes. - Stock Titan
A required tax-withholding sale: Twist Bioscience (TWST) HR executive Paula Green sells 294 shares. - Stock Titan
Twist Bioscience Corporation (TWST) stock price, news, quote and history - uk.finance.yahoo.com
Twist Bioscience Corporation (TWST) Latest Stock News & HeadlinesYahoo Finance - Yahoo! Finance Canada
Twist Bioscience stock holds near 52-week high after CEO share sale - AD HOC NEWS
After $56M sale, Twist Bioscience (NASDAQ: TWST) insider plans more - Stock Titan
Twist Bioscience (TWST) officer to sell shares to cover tax on equity award - Stock Titan
After $1.8M stock sale, Twist Bioscience (NASDAQ: TWST) insider files to sell more - Stock Titan
Twist Bioscience CEO Emily Leproust sells $56.3m in company stock By Investing.com - Investing.com South Africa
Twist Bioscience(TWST.US) Officer Sells US$56.33 Million in Common Stock - Moomoo
Twist Bioscience (TWST) CEO trades 356K shares at up to $163.60 - Stock Titan
Twist Bioscience CEO Emily Leproust sells $56.3m in company stock - Investing.com
Twist Bioscience CorporationCommon Stock (NQ: TWST - The Chronicle-Journal
Twist Bioscience (NASDAQ: TWST) holder eyes $44.7M stock sale - Stock Titan
New multimillion-dollar stock sale planned at Twist Bioscience (NASDAQ: TWST) - Stock Titan
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery - Business Wire
LuxExperience, Alvotech, Twist Bioscience And Other Big Stocks Moving Higher On Wednesday - Benzinga
Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia - investing.com
Cathie Wood’s ARK sells Twist Bioscience stock, buys more Intellia By Investing.com - Investing.com Australia
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Twist Bioscience Corp-Aktie (TWST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Finn Patrick John | Officer |
Oct 23 '26 |
Proposed Sale |
134.59 |
2,245 |
302,153 |
0 |
| Laponis Adam | Chief Financial Officer |
Oct 09 '26 |
Sale |
156.30 |
2,462 |
384,823 |
98,114 |
| Laponis Adam | Officer |
Oct 09 '26 |
Proposed Sale |
156.30 |
2,462 |
384,823 |
0 |
| Leproust Emily M. | Officer |
Oct 05 '26 |
Proposed Sale |
202.15 |
4,548 |
919,374 |
0 |
| Leproust Emily M. | Chief Executive Officer |
Oct 05 '26 |
Sale |
202.15 |
4,548 |
919,374 |
562,760 |
| Green Paula | SVP of Human Resources |
Oct 02 '26 |
Sale |
188.88 |
10,088 |
1,905,462 |
106,632 |
| Leproust Emily M. | Chief Executive Officer |
Oct 02 '26 |
Sale |
188.88 |
45,736 |
8,638,799 |
567,308 |
| WERNER ROBERT F. | Officer |
Oct 02 '26 |
Proposed Sale |
188.88 |
1,482 |
279,926 |
0 |
| Cho Dennis | Officer |
Oct 02 '26 |
Proposed Sale |
188.88 |
9,514 |
1,797,040 |
0 |
| Leproust Emily M. | Officer |
Oct 02 '26 |
Proposed Sale |
188.88 |
45,736 |
8,638,789 |
0 |
0.12%
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):